PROM1 and neoplasm: However, with advancement of knowledge in this concept, the well-accepted cancer stem cell surface markers are CD44, CD24, CD133, CD166, EpCAM, and so forth, in different tumours including breast, lung, pancreas, prostate, colorectal, renal, and ovarian, while the prognostic value of these markers is still under investigation.